2 completed, 1 withdrawn. 3 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Completed 2, Withdrawn 1 |
Follow merphos: new trials by email Literature Review of merphos trials Research Report on merphos
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Continuous Intraventricular Methotrexate in Treating Patients With Leptomeningeal Disease pharmacological study, methotrexate - Leptomeningeal Metastases | Not applicable | Withdrawn | City of Hope Medical Center | 2012-09-01 | 2012-11-09 | |
| Cyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating Patients With Myelofibrosis, Acute Myeloid Leukemia, or Myelodysplastic Syndrome cyclophosphamide, busulfan, tacrolimus - Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Not applicable | Completed | Fred Hutchinson Cancer Center | 52 | 2006-12-01 | 2018-01-02 |
| Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia prednisone, vincristine sulfate, daunorubicin hydrochloride - T-cell Childhood Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia | Not applicable | Completed | National Cancer Institute (NCI) | 100 | 2001-04-01 | 2013-01-16 |
Chromosome 5q Deletion Syndrome (1) · Congenital Abnormalities (1) · Leukemia, Myeloid, Acute (1) · Meningeal Carcinomatosis (1) · Polycythemia Vera (1) · Primary Myelofibrosis (1) · Thrombocythemia, Essential (1)
City of Hope Medical Center (1) · Fred Hutchinson Cancer Center (1) · National Cancer Institute (NCI) (1)
United States (2)
Andrew Rezvani (1) · Kimberly Dunsmore (1) · Mike Chen, MD (1)
P01HL036444 (1), U10CA098543 (1)